Variant report

Variant	esv3374116
Chromosome Location	chr7:26436952-26439800
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:620)
CpG islands
(count:611)
Chromatin interactive
region (count:4)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:620 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr7:26438525-26438545	K562	blood:	n/a	n/a
2	ATF2	chr7:26438486-26439046	GM12878	blood:	n/a	n/a
3	ATF2	chr7:26438448-26439103	GM12878	blood:	n/a	n/a
4	BACH1	chr7:26437713-26439170	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr7:26437795-26438162	K562	blood:	n/a	n/a
6	BATF	chr7:26438533-26438966	GM12878	blood:	n/a	n/a
7	BCL11A	chr7:26438499-26439077	GM12878	blood:	n/a	n/a
8	BCL11A	chr7:26438573-26438880	GM12878	blood:	n/a	n/a
9	BCLAF1	chr7:26437669-26439144	GM12878	blood:	n/a	chr7:26438119-26438132 chr7:26437842-26437855
10	BCLAF1	chr7:26438392-26439099	GM12878	blood:	n/a	n/a
11	BHLHE40	chr7:26437679-26439022	K562	blood:	n/a	n/a
12	BHLHE40	chr7:26437754-26439117	GM12878	blood:	n/a	n/a
13	BRCA1	chr7:26438606-26438757	GM12878	blood:	n/a	n/a
14	CBX3	chr7:26438492-26439187	K562	blood:	n/a	n/a
15	CCNT2	chr7:26437746-26439019	K562	blood:	n/a	n/a
16	CEBPB	chr7:26438550-26439062	H1-hESC	embryonic stem cell:	n/a	n/a
17	CEBPB	chr7:26438769-26439022	K562	blood:	n/a	n/a
18	CEBPB	chr7:26438656-26439153	Hela-S3	cervix:	n/a	n/a
19	CEBPB	chr7:26438443-26439299	GM12878	blood:	n/a	n/a
20	CEBPB	chr7:26437609-26437806	H1-hESC	embryonic stem cell:	n/a	n/a
21	CHD1	chr7:26437601-26437877	H1-hESC	embryonic stem cell:	n/a	chr7:26437679-26437689
22	CHD1	chr7:26437794-26439010	GM12878	blood:	n/a	n/a
23	CHD1	chr7:26438702-26438894	H1-hESC	embryonic stem cell:	n/a	n/a
24	CHD2	chr7:26438477-26439079	GM12878	blood:	n/a	n/a
25	CHD2	chr7:26438322-26438478	H1-hESC	embryonic stem cell:	n/a	n/a
26	CHD2	chr7:26438911-26439158	K562	blood:	n/a	n/a
27	CHD2	chr7:26438718-26438884	H1-hESC	embryonic stem cell:	n/a	n/a
28	CHD2	chr7:26438112-26439032	Hela-S3	cervix:	n/a	n/a
29	CREB1	chr7:26437893-26439146	GM12878	blood:	n/a	n/a
30	CREB1	chr7:26437657-26437936	A549	lung:	n/a	n/a
31	CTBP2	chr7:26437607-26439174	H1-hESC	embryonic stem cell:	n/a	n/a
32	CTCF	chr7:26438460-26438610	WERI-Rb-1	eye:	n/a	n/a
33	CTCF	chr7:26437760-26437910	GM12875	blood:	n/a	n/a
34	CTCF	chr7:26437920-26438070	GM12869	blood:	n/a	chr7:26437939-26437952 chr7:26437939-26437948
35	CTCF	chr7:26439000-26439150	Hela-S3	cervix:	n/a	n/a
36	CTCF	chr7:26437900-26438050	HRE	kidney:	n/a	chr7:26437939-26437952 chr7:26437939-26437948
37	CTCF	chr7:26438920-26439170	MCF-7	breast:	n/a	n/a
38	CTCF	chr7:26438655-26438670	MCF-7	breast:	n/a	n/a
39	CTCF	chr7:26437780-26437930	BJ	skin:	n/a	n/a
40	CTCF	chr7:26437660-26437810	HepG2	liver:	n/a	n/a
41	CTCF	chr7:26437720-26437870	GM12871	blood:	n/a	n/a
42	CTCF	chr7:26439000-26439150	HUVEC	blood vessel:	n/a	n/a
43	CTCF	chr7:26437740-26437890	GM12878	blood:	n/a	n/a
44	CTCF	chr7:26437640-26437790	GM12872	blood:	n/a	n/a
45	CTCF	chr7:26437717-26437788	GM19240	blood:	n/a	n/a
46	CTCF	chr7:26437800-26437950	GM12864	blood:	n/a	chr7:26437939-26437948
47	CTCF	chr7:26438980-26439130	AG09319	gingival:	n/a	n/a
48	CTCF	chr7:26438980-26439130	NB4	blood:	n/a	n/a
49	CTCF	chr7:26437780-26437930	K562	blood:	n/a	n/a
50	CTCF	chr7:26437681-26437890	GM19238	blood:	n/a	n/a

(count:611 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:26437999-26438049	A549	lung:	n/a
2	chr7:26437999-26438049	A549	lung:	n/a
3	chr7:26438411-26438461	NHDF-neo	bronchial:	n/a
4	chr7:26437999-26438049	HRCEpiC	kidney:	n/a
5	chr7:26437681-26437731	HNPCEpiC	eye:	n/a
6	chr7:26437999-26438049	NB4	blood:	n/a
7	chr7:26437192-26437242	NH-A	brain:	n/a
8	chr7:26438411-26438461	SK-N-SH_RA	brain:	n/a
9	chr7:26437002-26437052	MCF10A-Er-Src	breast:	n/a
10	chr7:26437002-26437052	SAEC	small airway:	n/a
11	chr7:26438242-26438292	GM19239	blood:	n/a
12	chr7:26438304-26438354	HPAEpiC	pulmonary alveolar:	n/a
13	chr7:26438411-26438461	AG04450	lung:	fetal
14	chr7:26437192-26437242	BE2_C	brain:	n/a
15	chr7:26437192-26437242	ProgFib	skin:	n/a
16	chr7:26437999-26438049	PrEC	prostate:	n/a
17	chr7:26438242-26438292	K562	blood:	n/a
18	chr7:26438236-26438286	AoSMC	blood vessel:	n/a
19	chr7:26438236-26438286	ECC-1	luminal epithelium:	n/a
20	chr7:26438898-26438948	GM19239	blood:	n/a
21	chr7:26438234-26438284	HCM	heart:	n/a
22	chr7:26438411-26438461	NH-A	brain:	n/a
23	chr7:26438304-26438354	HAEpiC	amniotic membrane:	n/a
24	chr7:26438242-26438292	HUVEC	blood vessel:	n/a
25	chr7:26438234-26438284	NHDF-neo	bronchial:	n/a
26	chr7:26437681-26437731	A549	lung:	n/a
27	chr7:26438234-26438284	IMR90	lung:	fetal
28	chr7:26437681-26437731	ECC-1	luminal epithelium:	n/a
29	chr7:26438411-26438461	HCPEpiC	choroid plexus:	n/a
30	chr7:26437681-26437731	BJ	skin:	n/a
31	chr7:26438898-26438948	HCM	heart:	n/a
32	chr7:26437999-26438049	SK-N-SH_RA	brain:	n/a
33	chr7:26438242-26438292	HCT-116	colon:	n/a
34	chr7:26437002-26437052	HCF	heart:	n/a
35	chr7:26438242-26438292	NT2-D1	testis:	n/a
36	chr7:26437681-26437731	MCF10A-Er-Src	breast:	n/a
37	chr7:26437192-26437242	SK-N-SH_RA	brain:	n/a
38	chr7:26437002-26437052	HEEpiC	esophagus:	n/a
39	chr7:26438411-26438461	HCT-116	colon:	n/a
40	chr7:26437192-26437242	HRPEpiC	eye:	n/a
41	chr7:26437192-26437242	HCT-116	colon:	n/a
42	chr7:26438236-26438286	BJ	skin:	n/a
43	chr7:26437681-26437731	PANC-1	pancreas:	n/a
44	chr7:26438898-26438948	ProgFib	skin:	n/a
45	chr7:26438898-26438948	AG09309	skin:	n/a
46	chr7:26438304-26438354	SAEC	small airway:	n/a
47	chr7:26437192-26437242	HL-60	blood:	n/a
48	chr7:26438304-26438354	MCF-7	breast:	n/a
49	chr7:26437999-26438049	ProgFib	skin:	n/a
50	chr7:26438411-26438461	GM12892	blood:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:70335612..70336128-chr7:26438488..26439026,2	NB4	blood:
2	chr7:26435194..26437360-chr7:26480063..26481898,2	K562	blood:
3	chr7:26438821..26439447-chr7:26540126..26541048,3	MCF-7	breast:
4	chr7:26438613..26440865-chr7:26441029..26444147,3	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SNX10-2	chr7:26438866-26439274	ENSG00000214870
2	lnc-SNX10-2	chr7:26438272-26438358	ENSG00000214870

No data

Variant related genes	Relation type
ENSG00000214870	TF binding region
ENSG00000214870	CpG island
RFX7	miRNA target sites

Extended variants
information (count: 103 )
Associated
traits (count: 76 )

Variant overlapped rSNPs/rCNVs (count:103 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs557615912	chr7:26437012-26437013	Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
2	rs79873712	chr7:26437042-26437043	Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
3	rs546293942	chr7:26437060-26437061	Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs558846999	chr7:26437075-26437076	Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs575440937	chr7:26437110-26437111	Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs116971881	chr7:26437120-26437121	Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs528490852	chr7:26437121-26437122	Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs541907686	chr7:26437138-26437139	Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs375119624	chr7:26437179-26437180	Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs538326494	chr7:26437231-26437232	Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs76538424	chr7:26437242-26437243	Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs529530848	chr7:26437260-26437261	Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs562007665	chr7:26437263-26437264	Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs554889107	chr7:26437272-26437273	Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs112426758	chr7:26437333-26437334	Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs530751422	chr7:26437377-26437378	Active TSS Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs560944913	chr7:26437423-26437424	Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs1229660	chr7:26437429-26437430	Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs570325535	chr7:26437442-26437443	Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs532820207	chr7:26437445-26437446	Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs546676039	chr7:26437508-26437509	Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs1229661	chr7:26437578-26437579	Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
23	rs535421016	chr7:26437619-26437620	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs555102627	chr7:26437656-26437657	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs568748157	chr7:26437666-26437667	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs537762556	chr7:26437686-26437687	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs192004893	chr7:26437752-26437753	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs376679501	chr7:26437890-26437891	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs557554858	chr7:26437909-26437910	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs577522615	chr7:26437925-26437926	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs545931523	chr7:26437940-26437941	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs553431360	chr7:26437959-26437960	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs573298639	chr7:26438090-26438091	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs542194735	chr7:26438107-26438108	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs561777843	chr7:26438110-26438111	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs530680463	chr7:26438160-26438161	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs2269895	chr7:26438188-26438189	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs373770855	chr7:26438221-26438222	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs563890762	chr7:26438283-26438284	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
40	rs1234952	chr7:26438296-26438297	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs535881214	chr7:26438299-26438300	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
42	rs566545474	chr7:26438327-26438328	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
43	rs529007105	chr7:26438378-26438379	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs7802020	chr7:26438412-26438413	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs568887008	chr7:26438454-26438455	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs537699377	chr7:26438456-26438457	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs542764742	chr7:26438459-26438460	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs112584271	chr7:26438461-26438462	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs577233494	chr7:26438492-26438493	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs7802172	chr7:26438508-26438509	Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:76)

Disease	PMID	Source
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Autism	22495311	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Cancer	21637783	CNVD
Squamous cell cancer	20885788	CNVD
Breast cancer	16397240	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Glioblastoma multiforme	18628472	CNVD
Non-syndromic sensorineural hearing loss	22570644	CNVD
Cancer	21183584	CNVD
abnormal development	18461090	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	21785460	CNVD
Follicular lymphoma	20505157	CNVD
Williams-beuren syndrome	22470819	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	21645411	CNVD
Lung adenocarcinoma	17086460	CNVD
Colorectal cancer	19455253	CNVD
Lung cancer	17086460	CNVD
Breast cancer	18852474	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:498 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:26428200-26437400	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr7:26430200-26437200	Weak transcription	Brain Germinal Matrix	brain
3	chr7:26434000-26437600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
4	chr7:26435800-26437600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
5	chr7:26436000-26437400	Enhancers	Primary hematopoietic stem cells short term culture	blood
6	chr7:26436000-26438600	Enhancers	Fetal Brain Male	brain
7	chr7:26436400-26437400	Enhancers	Fetal Kidney	kidney
8	chr7:26436400-26437600	Enhancers	Fetal Brain Female	brain
9	chr7:26436600-26437000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
10	chr7:26436600-26437000	Bivalent Enhancer	Fetal Thymus	thymus
11	chr7:26436600-26437000	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
12	chr7:26436600-26437400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
13	chr7:26436600-26437400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
14	chr7:26436600-26437400	Enhancers	Fetal Lung	lung
15	chr7:26436600-26437400	Enhancers	Fetal Muscle Leg	muscle
16	chr7:26436600-26437400	Enhancers	Fetal Stomach	stomach
17	chr7:26436600-26437400	Enhancers	Skeletal Muscle Male	skeletal muscle
18	chr7:26436600-26437600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
19	chr7:26436600-26437600	Enhancers	Primary B cells from peripheral blood	blood
20	chr7:26436600-26437800	Enhancers	Spleen	Spleen
21	chr7:26436800-26437000	Enhancers	ES-I3 Cell Line	embryonic stem cell
22	chr7:26436800-26437000	Bivalent Enhancer	GM12878-XiMat	blood
23	chr7:26436800-26437200	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
24	chr7:26436800-26437200	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
25	chr7:26436800-26437200	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
26	chr7:26436800-26437400	Enhancers	HUES48 Cell Line	embryonic stem cell
27	chr7:26436800-26437400	Enhancers	HUES6 Cell Line	embryonic stem cell
28	chr7:26436800-26437400	Enhancers	HUES64 Cell Line	embryonic stem cell
29	chr7:26436800-26437400	Enhancers	Adipose Nuclei	Adipose
30	chr7:26436800-26437400	Enhancers	Colon Smooth Muscle	Colon
31	chr7:26436800-26437600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
32	chr7:26437000-26437200	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
33	chr7:26437000-26437400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
34	chr7:26437000-26437400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
35	chr7:26437000-26437400	Enhancers	Colonic Mucosa	Colon
36	chr7:26437000-26437400	Enhancers	Duodenum Smooth Muscle	Duodenum
37	chr7:26437000-26437400	Enhancers	Fetal Intestine Large	intestine
38	chr7:26437000-26437400	Enhancers	Rectal Mucosa Donor 29	rectum
39	chr7:26437000-26437400	Enhancers	Skeletal Muscle Female	skeletal muscle
40	chr7:26437000-26437600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr7:26437000-26437600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
42	chr7:26437000-26437600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
43	chr7:26437000-26437600	Enhancers	Fetal Intestine Small	intestine
44	chr7:26437000-26437600	Enhancers	Placenta	Placenta
45	chr7:26437000-26437800	Bivalent/Poised TSS	Primary T cells from cord blood	blood
46	chr7:26437000-26438000	Enhancers	Fetal Heart	heart
47	chr7:26437200-26437400	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
48	chr7:26437200-26437400	Enhancers	iPS-18 Cell Line	embryonic stem cell
49	chr7:26437200-26437400	Enhancers	iPS-20b Cell Line	embryonic stem cell
50	chr7:26437200-26437400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links